NBTXR3

hafnium oxide nanoparticles · Nanobiotix

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for NBTXR3, covering 2021-04-06 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer [Phase 1]